Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Boston Scientific Corp. (NYSE: BSX).

Full DD Report for BSX

You must become a subscriber to view this report.


Recent News from (NYSE: BSX)

Boston Scientific (BSX) CRM and Electrophysiology Products Overview - Slideshow
The following slide deck was published by Boston Scientific Corporation in conjunction with this Read more ...
Source: SeekingAlpha
Date: May, 14 2018 14:17
Boston Scientific To Participate In 34th Annual Strategic decisions Conference
MARLBOROUGH, Mass. , May 14, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 34 th Annual Strategic Decisions Conference on May 31, 2018 in New York . Mike Mahoney , chairman and chief executive officer, will participat...
Source: PR Newswire
Date: May, 14 2018 08:30
Boston Scientific announces real-world data demonstrating success of SMART pass on the S-ICD system
Boston Scientific (NYSE: BSX ) announces  the results of its database analysis evaluating the reduction of inappropriate shocks by using its SMART Pass sensing filter in patients implanted with the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) System. More news on: Bosto...
Source: SeekingAlpha
Date: May, 14 2018 08:26
Stocks To Watch: A Fed Head Talks Crypto
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Cryptocurrencies are in the spotlight this week during Blockchain Week in New York ...
Source: SeekingAlpha
Date: May, 12 2018 09:16
Boston Scientific Announces Real-World Data Demonstrating Success Of SMART Pass On The S-ICD System
MARLBOROUGH, Mass. , May 11, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced results from an analysis of the LATITUDE database which evaluated the successful reduction of inappropriate shocks using the SMART Pass sensing filter in patients implanted with the EMBLEM...
Source: PR Newswire
Date: May, 11 2018 18:00
Boston Scientific subject of 60 minutes report May 13
CBS' 60 Minutes will feature a report this Sunday, May 13, on the 48K lawsuits facing Boston Scientific (NYSE: BSX ) related to its transvaginal mesh device. More news on: Boston Scientific Corporation, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 11 2018 07:39
Ad Com June 12 for Cardinal's InCraft stent; shares ahead 6%
The FDA's Medical Devices Advisory Committee's Circulatory Systems Devices Panel will meet on Tuesday, June 12, to discuss the marketing application from Cardinal Health's ( CAH +5.6% ) Cordis unit seeking approval for its InCraft AAA Stent Graft System for the treatment of infrarenal ab...
Source: SeekingAlpha
Date: May, 10 2018 11:33
Boston Scientific To Participate In Bank of America Merrill Lynch 2018 Health Care Conference
MARLBOROUGH, Mass. , May 7, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2018 Health Care Conference on May 16, 2018 in Las Vegas . Dan Brennan , executive vice president and chief financial...
Source: PR Newswire
Date: May, 07 2018 11:11
RiverPark Short Term High Yield Fund And RiverPark Strategic Income Fund Q1 2018 Commentary
Read more ...
Source: SeekingAlpha
Date: May, 02 2018 01:54
Boston Scientific Closes NxThera Acquisition
MARLBOROUGH, Mass. , April 30, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of NxThera. The company developed the Rezūm ® system, a minimally invasive therapy ( MIT ) for patients with symptomatic be...
Source: PR Newswire
Date: April, 30 2018 06:30

 


About Boston Scientific Corp. (NYSE: BSX)

Logo for Boston Scientific Corp. (NYSE: BSX)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $41,352,920,745 - 05/11/2018
  • Issue and Outstanding: 1,379,810,502 - 04/25/2018

 


Recent Filings from (NYSE: BSX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 11 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: April, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 28 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 23 2018
Prospectus filed under Rule 424(b)(2)
Filing Type: 424B2Filing Source: edgar
Filing Date: February, 23 2018

 

 


Daily Technical Chart for (NYSE: BSX)

Daily Technical Chart for (NYSE: BSX)


Stay tuned for daily updates and more on (NYSE: BSX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: BSX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BSX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of BSX and does not buy, sell, or trade any shares of BSX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/